Home›Companies›Biotech & Pharma›VQ Biomedical

VQ Biomedical, Inc.

Updated Oct 27, 2026·Latest SEC filing Mar 27, 2025·Suggest an edit

About VQ Biomedical

VQ Biomedical is a private company based in Apex, North Carolina, incorporated in 2023 in Delaware. It has reported $1,650,000 raised in one offering on Form D since March 2025. Its chief executive is Galen Robertson.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 31, 2024Mar 27, 2025$1,650,000fully sold21$78,571DebtRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on VQ Biomedical's Form D filed Mar 27, 2025.

MD
TS
Tobias Straube
Executive officer and director
DE
Daniel Estay
Director
GR
Galen Robertson
Chief Executive Officer and director
JK
Joe Knight
Director

Sources

  1. SECVQ Biomedical, Inc. filing history